October 14: The Week in Cancer News
Colonoscopy study results are misreported, progress is seen in cancer vaccines, and more from the week in cancer news.
Progress Against Cancer
Colonoscopy study results are misreported, progress is seen in cancer vaccines, and more from the week in cancer news.
Clinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
Transportation barriers increase risk of death for people with cancer, and new rules go into effect to give patients full access to medical records.
Lowering and increasing alcohol consumption is associated with changes in cancer risk.
The FDA granted accelerated approval to a new targeted therapy for certain patients with advanced or metastatic cholangiocarcinoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to futibatinib (Lytgobi) for adult...
Firefighters face increased cancer risk due to exposure to ‘forever chemicals,’ and cancer-related fatigue can put breast cancer survivors at risk for falls.
Adolescents and young adults diagnosed with cancer often lag behind children and older adults in benefiting from treatment advances and social support.
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
The AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now